Core Viewpoint - The company announced that its weight-loss drug will be available at the same self-pay price in both single-dose vial format and multi-dose pen format, which allows for four weekly injections from a single device [1] Group 1 - The weight-loss drug will be offered in two formats: single-dose vials and multi-dose pens [1] - The multi-dose pen format enables patients to receive four weekly injections from one device [1]

Eli Lilly & Co. failed to win backing from the European Union’s medicines regulator for the use of its weight-loss drug Mounjaro to treat a certain kind of heart failure in adults with obesity. https://t.co/rRsvbblOK6 ...

Novo Nordisk has received FDA approval to sell an oral version of Wegovy in the US. This could boost its efforts to regain ground in the weight-loss drug market. Here's what to know. https://t.co/cNwH6MWXnR ...

Regulatory Approval - FDA approves daily pill version of weight-loss drug Wegovy, providing a new administration option for GLP-1 medication [1]

Regulatory Approval - FDA approves daily pill version of weight-loss drug Wegovy, providing a new option for patients taking GLP-1 medication [1] Pharmaceutical Industry - The approval introduces a new formulation for a GLP-1 medication, potentially impacting the weight-loss drug market [1]

Drug Pricing - Eli Lilly is reducing the price of its weight-loss drug Zepbound on its LillyDirect platform [1] - The price reduction follows a deal with the Trump administration to lower drug costs [1]

Group 1 - The article highlights the ongoing construction in Kalundborg, Denmark, to accommodate the increasing demand for Novo Nordisk's Wegovy weight-loss drug [1] - The town of Kalundborg is referred to as "Novo Town," indicating its strong association with Novo Nordisk and its operations [1] - Therapist Heidi Thron Rune has adapted to the noise from the construction, reflecting the significant impact of Novo Nordisk's business on the local community [1]

Novo Nordisk lowers its financial forecast in a surprise update, citing lagging sales of its weight-loss drug Wegovy as it fights to regain its leading position in the obesity market https://t.co/LeXFsFYwwh ...